Price T Rowe Associates Inc Biolife Solutions Inc Transaction History
Price T Rowe Associates Inc
- $867 Billion
- Q4 2024
A detailed history of Price T Rowe Associates Inc transactions in Biolife Solutions Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 19,439 shares of BLFS stock, worth $466,536. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,439
Previous 16,811
15.63%
Holding current value
$466,536
Previous $421,000
19.95%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding BLFS
# of Institutions
188Shares Held
47.1MCall Options Held
4.3KPut Options Held
4.7K-
Casdin Capital, LLC New York, NY8.71MShares$209 Million19.45% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$132 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA3.24MShares$77.7 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.84MShares$68.1 Million0.0% of portfolio
-
Fred Alger Management, LLC New York, NY1.59MShares$38.3 Million0.21% of portfolio
About BIOLIFE SOLUTIONS INC
- Ticker BLFS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 42,684,400
- Market Cap $1.02B
- Description
- BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...